Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2009-05-04
2010-12-28
Badio, Barbara P (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C552S554000
Reexamination Certificate
active
07858608
ABSTRACT:
The present invention relates to compounds of formula (I)wherein:R1is hydrogen or an alkyl group;R2is hydrogen or a halogen, nitro, alkyloxy, amino or carboxy group;Y is CH2, oxygen or sulfur;n is an integer from 1 to 4, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof for the treatment of FXR-mediated diseases or conditions.
REFERENCES:
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, pp. 217-218 (in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227).
Vippagunta et al. (Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26).
Fiorucci Stefano
Pellicciari Roberto
Pruzanski Mark
Badio Barbara P
Elrifi, Esq. Ivor R.
Intercept Pharmaceuticals, Inc.
Loebach, Esq. Jennifer
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Bile acid derivatives as FXR ligands for the prevention or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bile acid derivatives as FXR ligands for the prevention or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bile acid derivatives as FXR ligands for the prevention or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4217856